These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11905140)

  • 1. NIAID and Merck to collaborate on HIV vaccine development.
    AIDS Read; 2002 Feb; 12(2):60. PubMed ID: 11905140
    [No Abstract]   [Full Text] [Related]  

  • 2. NIAID, Wyeth create AIDS vaccine team.
    AIDS Policy Law; 2002 Jun; 17(11):1. PubMed ID: 12083033
    [No Abstract]   [Full Text] [Related]  

  • 3. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 4. NIAID and Merck collaborate on HIV vaccine.
    AWHONN Lifelines; 2002; 6(1):15. PubMed ID: 11913194
    [No Abstract]   [Full Text] [Related]  

  • 5. NIAID funds center for HIV/AIDS vaccine immunology.
    AIDS Policy Law; 2005 Jul; 20(14):2. PubMed ID: 16108120
    [No Abstract]   [Full Text] [Related]  

  • 6. AlphaVax receives NIAID contract to support development of HIV vaccine.
    Expert Rev Vaccines; 2003 Dec; 2(6):731-2. PubMed ID: 15282844
    [No Abstract]   [Full Text] [Related]  

  • 7. NIAID declines to proceed with HIV vaccine trial.
    AIDS Policy Law; 2008 Aug; 23(9):1, 4. PubMed ID: 18780467
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV vaccine strategy seeks to woo industry.
    Wadman M
    Nature; 1996 Feb; 379(6567):665. PubMed ID: 8602205
    [No Abstract]   [Full Text] [Related]  

  • 9. New branch created by the NIAID to promote HIV vaccine development.
    Expert Rev Vaccines; 2008 Aug; 7(6):709. PubMed ID: 18665768
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV vaccine holds promise of global effectiveness.
    J Calif Dent Assoc; 2003 Jan; 31(1):13. PubMed ID: 12583445
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV vaccine best hope for controlling AIDS, says NNIH.
    AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083036
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparations for AIDS vaccine trials. Intellectual property issues related to AIDS vaccine development from a federal laboratory perspective.
    Mays TD; Maurey K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S301. PubMed ID: 7865325
    [No Abstract]   [Full Text] [Related]  

  • 13. NIAID to test new AIDS vaccines on pregnant women with HIV.
    Doepel LK
    Public Health Rep; 1993; 108(4):526-7. PubMed ID: 8341791
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH examines 2 decades of HIV vaccine progress.
    AIDS Policy Law; 2007 Jun; 22(11):4. PubMed ID: 17619275
    [No Abstract]   [Full Text] [Related]  

  • 15. NIAID to convene HIV vaccine summit.
    AIDS Patient Care STDS; 2008 Apr; 22(4):350-1. PubMed ID: 18434951
    [No Abstract]   [Full Text] [Related]  

  • 16. NIAID funds new groups to develop HIV vaccines.
    Watanabe ME
    Nat Med; 2000 Aug; 6(8):844. PubMed ID: 10932202
    [No Abstract]   [Full Text] [Related]  

  • 17. NIAID begins enrolling volunteers for Phase IIB study of Merck's vaccine.
    IAVI Rep; 2004 Dec-2005 Mar; 9(1):16. PubMed ID: 16114115
    [No Abstract]   [Full Text] [Related]  

  • 18. Progenics to develop HIV vaccine.
    Expert Rev Vaccines; 2004 Jun; 3(3):229-30. PubMed ID: 15176938
    [No Abstract]   [Full Text] [Related]  

  • 19. Fed help Atlanta firm hunt for AIDS vaccine.
    AIDS Read; 2007 Dec; 17(12):582. PubMed ID: 18178974
    [No Abstract]   [Full Text] [Related]  

  • 20. Volunteers sought for NIH AIDS vaccine study.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.